Институт полиомиелита им. М.П. Чумакова РАН
Федеральный научный центр исследований и разработки иммунобиологических препаратов им. М.П. Чумакова РАН (Институт полиомиелита)
To ensure the safety of employees and prevent the spread of coronavirus infection (COVID-19) in the Federal State Budgetary Scientific Institution “FNTSIRIP them. M.P. Chumakov RAS” the following urgent measures are being taken in accordance with the order of the First Deputy General Director dated March 19, 2020 No. 21
Employees are familiar with Decree of the Mayor of Moscow No. 12-UM dated March 5, 2020 “On the introduction of a high alert regime”, Decree of the Moscow Mayor No. 21-UM dated March 16, 2020 “On amending the Decree of the Moscow Mayor dated March 5 2020 No. 12-UM” and the need to comply with […]
Employees are familiar with Decree of the Mayor of Moscow No. 12-UM dated March 5, 2020 “On the introduction of a high alert regime”, Decree of the Moscow Mayor No. 21-UM dated March 16, 2020 “On amending the Decree of the Moscow Mayor dated March 5 2020 No. 12-UM” and the need to comply with preventive measures to prevent the spread of infection recommended by WHO and Rospotrebnadzor. Preventive measures are observed at the workplace: treatment of premises with disinfectants; regular (every 2 hours) airing of working premises; shutdown of air-conditioning and technical ventilation systems in working premises. Regular thermometry is carried out, suspension from work and registration of employees with signs of SARS. Restrictive measures for visitors, including thermometry and refusal to enter the territory, if a visitor has an elevated body temperature (above 37.2 ° C). Measures are being taken to optimize work schedules in order to prevent crowding at the checkpoint, in the premises for meals and travel of employees in public transport during peak hours, and the possibility of remote work is organized for employees 65 years of age and older. The number of business mass events has been reduced as much as possible or transferred to a remote mode.
September 12, 2020 marks 65 years since the Institute for the Study of Poliomyelitis, renamed in 1960 as the Institute of Poliomyelitis and Viral Encephalitis of the Academy of Medical Sciences, was organized by order of the Minister of Health of the USSR No. USSR. In record time, technologies for the industrial production of vaccines […]
September 12, 2020 marks 65 years since the Institute for the Study of Poliomyelitis, renamed in 1960 as the Institute of Poliomyelitis and Viral Encephalitis of the Academy of Medical Sciences, was organized by order of the Minister of Health of the USSR No. USSR. In record time, technologies for the industrial production of vaccines against poliomyelitis and their large-scale production were created and mastered. Simultaneously with the successful development of the polio eradication program, the introduction of this program into action and its further development, the Institute developed methods of protection against other viral diseases. In 2016, on the basis of the Institute of Poliomyelitis, the Federal Scientific Center for Research and Development of Immunobiological Preparations named after M.P. Chumakov RAS. The current generation of employees of our Center honors and develops the traditions of their predecessors. At present, the Center named after M.P. Chumakova is a recognized leader in the field of medical virology, molecular biology of viruses, immunology, in the development of modern methods for diagnosing and preventing viral infections. The intellectual and technical potential of the Center makes it possible to cover the entire cycle of work on the creation of new immunobiological preparations – from the creation of a drug concept to the preparation of finished vaccines and their preclinical trials. On the Day of the 65th anniversary of the Institute for the Study of Poliomyelitis, please accept my congratulations and wishes for good health, the implementation of your creative plans and ideas, well-being and happiness! General Director of “FNCIRIP them. M.P. Chumakov RAS “A.A. Ishmukhametov
Enterprise of the Institute of Poliomyelitis and Viral Encephalitis. M.P.Chumakova carried out a complete modernization of production
By the end of 2014, at the enterprise of the Institute of Poliomyelitis and Viral Encephalitis. MP Chumakov completed the modernization and technical re-equipment of all production units in accordance with international GMP standards. The available facilities, software and spare parts are sufficient to provide the entire population of the Russian Federation with the necessary […]
By the end of 2014, at the enterprise of the Institute of Poliomyelitis and Viral Encephalitis. MP Chumakov completed the modernization and technical re-equipment of all production units in accordance with international GMP standards. The available facilities, software and spare parts are sufficient to provide the entire population of the Russian Federation with the necessary drugs. Technical modernization has established a number of functional systems for training and professional development of personnel, for auditing suppliers of equipment, raw materials and consumables; on feedback from customers, post-marketing monitoring of the quality of released vaccines and pharmacovigilance for the occurrence of possible side effects from their use. After the completion of the technical re-equipment, the enterprise is a modern research and production complex that produces medical products for the prevention, diagnosis and treatment of viral diseases. The enterprise produces vaccines against poliomyelitis, yellow fever, rabies, tick-borne encephalitis, and diagnostic sera. On the Russian market, drugs produced by the Federal State Unitary Enterprise “Enterprise of the Institute of Poliomyelitis and Viral Encephalitis named after A.I. M.P. Chumakov” occupy up to 80% of the market demand in their segments. “For many years, our company has been providing Russia and the CIS countries with vaccines that fully meet international quality standards. The technical modernization of production will allow us not only to increase the volume of products for the domestic market, but also to increase Russia’s share in the supply of vaccines for international charitable organizations such as WHO and Unicef ​​up to 40%, ”said the director of the enterprise of the Institute of Poliomyelitis and Viral Encephalitis. M.P. Chumakov Aidar Ishmukhametov. Currently, the company is the largest manufacturer and exporter of vaccines in Russia and the CIS countries and the only one who has WHO permission to supply vaccines for charitable programs through UN agencies (WHO, UNICEF, PAHO). Bringing the production unit in line with international GMP standards brought the enterprise of the Institute of Poliomyelitis and Viral Encephalitis named after. M.P. Chumakov in the lead among domestic and foreign manufacturers. As a result of the technical re-equipment of the enterprise, it became possible to develop new vaccines that have no analogues in the world. Enterprise of the Institute. MP Chumakova is developing a domestic vaccine As part of the replacement of foreign inactivated vaccine, which is now purchased by the state under the National Immunization Schedule, the Enterprise of the Institute of Poliomyelitis. M.P. Chumakov is developing a domestic vaccine, which is a strategically important drug. In 2 years, the vaccine will be launched into mass production. It is expected that the Russian drug will be 3-5 times cheaper than foreign analogues. Currently, the Enterprise of the M.P. Chumakov Polio Institute is faced with the task of replacing foreign vaccines with domestic ones in order to ensure the national security of the country and save budgetary funds. Thus, the cost of the National Immunization Schedule for the current year is more than 10 billion rubles, while only the cost of two drugs produced with the participation of foreign companies “eats up” 60% of this budget. “Domestic vaccines are much cheaper than imported ones – now the state buys them at a price almost lower than the cost. Since manufacturing enterprises are state institutions, and, as a rule, the only suppliers of the drug on the market, they do not only sell their goods, but perform an important social function to protect the national security of Russia, ”said the director of the Enterprise of the Institute of Poliomyelitis and Viral Encephalitis named after. M.P. Chumakov Aidar Ishmukhametov. Also, the Enterprise of the Institute of Poliomyelitis and Viral Encephalitis. M.P. Chumakov RAMS launched the production of the first vaccine in Russia for the prevention of tick-borne encephalitis – Klesch-E-Vak, intended for children from 1 to 16 years of age. This drug, which meets all domestic and international standards, is much more affordable for the average consumer than the imported analogue.
General Director of the Center M.P. Chumakova Aidar Ishmukhametov was elected an academician to the department of medical sciences in the current elections of the Russian Academy of Sciences
<img loading="lazy" class="aligncenter wp-image-579 size-full" src="http://dev.ecashis.beget.tech/wp-content/uploads/2022/06/aydar-akademik.jpg" alt="" width="600" height="751" srcset="https://chumakovs.ru/wp-content/uploads/2022/06/aydar-akademik.jpg 600w, https://chumakovs.ru/wp-content/uploads/2022/06/aydar-akademik-240x300.jpg 240w, https://chumakovs.ru/wp-content/uploads/2022/06/aydar-akademik-120x150.jpg 120w" sizes="(max-width: 600px) 100vw, 600px" />